Owlet (OWLT) Non-Current Deffered Revenue (2020 - 2021)
Owlet (OWLT) posted quarterly Non-Current Deffered Revenue of $206000.0 for Q3 2021, down 97.44% year-over-year from $8.0 million in Q3 2020, and down 97.44% quarter-over-quarter from $8.0 million in Q2 2021.
Owlet (OWLT) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
Owlet (OWLT) has reported Non-Current Deffered Revenue for 2 consecutive years, with $206000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Non-Current Deffered Revenue fell 97.44% year-over-year to $206000.0; the TTM figure through Sep 2021 stood at $206000.0 (down 97.44% YoY), while the FY2020 annual figure was $322000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue fell to $206000.0 in Q3 2021 per OWLT's latest filing, from $8.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $8.0 million in Q3 2020 and bottomed at $206000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Owlet | 159.40 Mn | 122.85 Mn | 21.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 8.05 Mn |
| Mar 31, 2021 | 8.05 Mn |
| Dec 31, 2020 | 322,000.00 |
| Sep 30, 2020 | 8.05 Mn |